Chronic or delayed healing wounds constitute an ever‐increasing burden on healthcare
providers and patients alike. Thus, therapeutic modalities that are tailored to particular …

Since chronic, non-healing wounds represent an increasing source of economic and
temporal burden for patients who suffer from them and healthcare professionals that treat …

Significance: Chronic wounds can lead to poor outcomes for patients, with risks, including
amputation and death. In the United States, chronic wounds affect 2.5% of the population …

The early and effective treatment of wounds is vital to ensure proper wound closure and
healing with appropriate functional and cosmetic outcomes. The use of human amnion …

Background Chronic and recalcitrant wounds present a significant therapeutic challenge.
Amniotic tissues contain many regenerative cytokines, growth factors, and extracellular …

There is a need for effective wound treatments that retain the bioactivity of a cellular
treatment, but without the high costs and complexities associated with manufacturing …

Objective: Wound healing is a complex process involving the dynamic interplay of various
types of cells and bioactive factors. Impaired wound healing is characterized by a loss in …

Chronic wounds do not follow the usual wound healing process; instead, they are stuck in
the inflammatory or proliferative phase. This is particularly evident in large, massive wounds …

Introduction Wound healing is severely compromised in patients with diabetes owing to
factors such poor blood circulation, delayed immune response, elevated blood sugar levels …

Objective The aim of this study is to evaluate a viable human amnion membrane allograft
(vHAMA) for the treatment of chronic nonhealing wounds in elderly patients (aged> 65 …